Verano Holdings Corp
CNSX:VRNO
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
V
|
Verano Holdings Corp
CNSX:VRNO
|
1.7B CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
528.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.6B USD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Verano Holdings Corp
Glance View
In the burgeoning landscape of the cannabis industry, Verano Holdings Corp. emerges as a key player, crafting a narrative of growth and innovation. Founded with an ambition to bring premium cannabis products to the forefront of the market, Verano operates across a diverse array of segments, tapping into both the medicinal and recreational sectors. The company stands out due to its vertically integrated model, which means it controls the entire supply chain, from cultivation and production to distribution and retail. This model not only ensures quality and consistency but also allows Verano to capture value at every step of the process. Through meticulous cultivation practices and state-of-the-art facilities, Verano develops a wide range of products, including flower, edibles, and concentrates, which are distributed under its house of premium brands in various markets across North America. Verano's financial engine is powered by its extensive network of retail outlets—known as Zen Leaf and MÜV dispensaries—and its aggressive expansion strategy into emerging markets. This retail footprint is crucial, providing direct access to consumers and fostering a loyal customer base. Verano continuously enhances its product offerings by focusing on innovation and responding adeptly to consumer trends, thereby driving sales and margin growth. Its adept navigation of complex regulatory environments reflects a keen understanding of market dynamics, allowing it to take advantage of growth opportunities in a sector that remains highly regulated. By marrying operational efficiency with a deep commitment to delivering high-quality, consistent cannabis products, Verano not only sustains profitability but also positions itself strategically for future growth in an evolving industry landscape.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Verano Holdings Corp is 9.8%, which is above its 3-year median of 7.8%.
Over the last 3 years, Verano Holdings Corp’s Operating Margin has increased from -9.2% to 9.8%. During this period, it reached a low of -12.1% on Mar 31, 2021 and a high of 10.2% on Jul 30, 2023.